Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Is Real-world Evidence Really Real?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Bevægeapparatets sygdomme

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  2. Galectin-3-binding protein is a novel predictor of venous thromboembolism in systemic lupus erythematosus

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Systemisk Sklerodermi: National Behandlingsvejledning

    Research output: Book/ReportReportCommunication

View graph of relations

OBJECTIVE: Neutrophil extracellular traps (NET) are essential in host defense, but are also linked to inflammation and autoimmunity, including in systemic lupus erythematosus (SLE). We recently described that immune complexes (IC) induce NET formation, promoting SLE-like disease in mice. In the current study, we investigated, for the first time to our knowledge, the role of NET in human SLE and their association with disease activity and severity.

METHODS: Levels of NET (myeloperoxidase-DNA complexes) were analyzed in plasma from 4 cross-sectional SLE cohorts (n = 44-142), 1 longitudinal SLE cohort (n = 47), and healthy individuals (n = 100) using ELISA. Type I interferon activity was determined using a cell reporter system.

RESULTS: Patients with SLE had elevated levels of NET in circulation compared to healthy controls (p < 0.01). NET levels identified patients with a severe disease phenotype characterized by IC-driven nephritis (p < 0.05). Though not associated with current disease activity (p = 0.20), levels of NET were associated with future increase in the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) within 3 months (OR 1.75, p = 0.01), as well as an overall heightened SLEDAI over 1 year (p < 0.01). Finally, levels of NET were associated with arterial events (OR 5.0, p = 0.02) and endothelial cell activation (p < 0.001).

CONCLUSION: NET levels are elevated in patients with SLE, associated with IC-driven disease. NET levels provide significant clinical value in identifying patients at risk of active disease and/or severe disease, including nephritis and cardiovascular disease, and may allow for early interventions.

Original languageEnglish
JournalJournal of Rheumatology
Issue number11
Pages (from-to)1652-1660
Number of pages9
Publication statusPublished - 1 Nov 2020

    Research areas

  • Cardiovascular disease, Nephritis, Neutrophil extracellular trap, Systemic lupus erythematosus

ID: 61875224